UBS/PUT/PFIZER INC/34/0.1/20.09.24 Share Price

Warrant

CH1280725644

Market Closed - Deutsche Boerse AG 17:08:12 03/07/2024 BST
0.59 EUR +3.51% Intraday chart for UBS/PUT/PFIZER INC/34/0.1/20.09.24
Current month+3.51%
1 month+28.26%
Date Price Change
03/07/24 0.59 +3.51%
02/07/24 0.57 +5.56%
01/07/24 0.54 -5.26%
28/06/24 0.57 -3.39%
27/06/24 0.59 -3.28%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 05:08 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer UBS
WKN UL4B78
ISINCH1280725644
Date issued 11/07/2023
Strike 34 $
Maturity 20/09/2024 (79 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.85
Lowest since issue 0.179
Delta-0.86x
Omega 3.575
Premium1.2x
Gearing4.18x
Moneyness 1.227
Difference Strike 6.3 $
Difference Strike %+18.53%
Spread 0.05
Spread %7.81%
Intrinsic value 0.5840

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus